Adenovirus vectors hold promise for applications such as somatic gene transfer, vaccine development and functional genomics. [1] [2] [3] [4] [5] Traditionally, recombinant adenovirus vectors were generated through homologous recombination in a human embryonic kidney fibroblast cell line, 293 cells, transfected with a plasmid containing the 5 0 portion of the viral genome and a 3 0 fragment of viral DNA segments ( Figure 1a) . 6, 7 The shuttle plasmid carries the minigene cassette of interest in the place of E1 sequences, whereas the 3 0 viral DNA could be from either an endonuclease restricted viral genome 6 or a plasmid vector containing the viral DNA. 8, 9 In the latter case, the homologous recombination could also be carried out in nonmammalian hosts such as bacteria [10] [11] [12] and yeast. 13 In addition, phage P1 Cre 14, 15 or yeast FLP 16 recombinase-mediated recombination process was also employed in the adenovirus vector creation. Although efficiency of adenovirus vector creation by homologous recombination in 293 cells was improved by a green/white selection process, 17 the initial isolates still consist of mixtures of recombinant viruses requiring a lengthy plaque-purification process to isolate a uniform species of virus. More recent advancements have simplified the process of adenovirus vector creation to a direct ligation and cloning procedure. [18] [19] [20] [21] The recombinant adenovirus vectors created in this way are single molecular clones, usually resulting in a homogenous population of recombinant virus after rescue from 293 cells. In general, due to the size of the molecular constructs (larger than 39 kb usually), generation of adenovirus vectors by direct cloning in Escherichia coli is not as efficient as other methods such as by homologous recombination in E. coli. Particularly, two steps in this method are critical to the efficiency of vector creation: rapidly isolating bacterial transformants containing correct recombinant vectors, and efficiently transfecting and rescuing molecular clones of recombinant adenoviruses in packaging cells.
The first aim of this study was to modify a molecular cloning procedure for recombinant genomes and make it compatible with high throughput vector creation. To this end, we incorporated a convenient green-white selection step into the direct cloning process for rapidly isolating bacterial transformants containing recombinant adenovirus plasmids. This significantly diminishes the numbers of transformant colonies to be screened by plasmid DNA minipreparations and restriction endonuclease analysis.
The second aim of this study was to improve the efficiency of virus rescue through enhancing transfection and in situ cleavage of circular adenovirus genomes. Since cellular concentration of the adenovirus genome delivered into 293 cells directly affects rates and efficiency of the virus rescue, 22 improvements in transfection efficiency of the adenovirus DNA into 293 cells could be helpful to the rescue process. Ideally, direct transfection of circular plasmids bearing viral genomes into 293 cells for rescue would expedite the rescue process. However, rescue of circular adenovirus genomes is usually inefficient due to a poor initiation of DNA synthesis from embedded ITRs. 23, 24 Pretreatment of molecular clones with restriction endonucleases is required to release linear adenovirus genomes from the plasmid backbone, which adds an extra step and reduces transfection efficiency. I-Sce I is an intron-encoding endonuclease present in the mitochondria of yeast Saccharomyces cerevisiae. Expression of I-Sce I in mammalian cells can cleave double-stranded DNAs carrying the specific recognition sites. [25] [26] [27] [28] [29] In this study, we took advantage of the specificity and effectiveness of I-Sce I-mediated cleavage to release the adenoviral vector genome from a circular plasmid in the cell after transfection. I-Sce I recognition sites were engineered into the vector plasmid outside the ITRs of adenovirus genomes in circular plasmids, which were transfected into 293 cells expressing I-Sce I endonuclease, leading to efficient release of the adenovirus linear genome in vivo. Thus, improvements in the adenovirus DNA delivery process by transfecting circular molecular clones were further complemented by efficient I-Sce I-mediated in situ cleavage, release of adenovirus termini and rescue of vector genomes ( Figure  1b) . Alternatively, we inserted a transcription unit expressing I-Sce I enzyme into the plasmid backbone that carries recombinant virus genomes flanked by I-Sce I recognition sites. Transfection of this self-cleaving plasmid into regular 293 cells resulted in expression of I-Sce I, resolution of virus termini and efficient rescue of viral genomes ( Figure 1c) .
A novel method was developed to simplify the isolation of molecular clones. A plasmid was created containing the entire adenoviral genome with sequences spanning E1a and E1b substituted with a prokaryotic To introduce an Aequorea victoria GFP-expressing cassette driven by an prokaryotic promoter (PK) into the pAdX plasmid (Clontech Laboratories, Palo Alto, CA, USA) between two intron-encoding rare endonuclease recognition sites (PI-Sce I and I-Ceu I), pShuttle plasmid (Clontech Laboratories, Palo Alto, CA, USA) was first converted into pShuttle-PK-GFP by isolating a 1.3 kb PVU II/Afl II fragment from pGFP-Mut 3.1 (Clonetech, Palo Alto, CA, USA) through a partial digestion and subcloning into Afl II and blunted Kpn I sites of pShuttle. The resulting construct, pShuttle-PK-GFP, has a multiple cloning site containing a wide-range selection of restriction sites such as AgeI, BamHI, EcoRV, KpnI, NotI, SalI and XbaI that are conveniently located between the cytomegalovirus early promoter (CMV) and SV40 poly A for inserting the genes of interest, and PI-Sce I/I-Ceu I sites that flank the CMV-cDNA-poly A cassette for subcloning the entire minigene cassette into adenovirus backbone plasmids. It serves as both a recipient plasmid for subcloning the cDNA of the gene of interest and a donor construct for creating pAd-PK-GFP by direct ligation at PI-Sce I and I-Ceu I sites through a convenient green-white colonyselection process. The pAd-PK-GFP transformants were identified as green colonies. The same green-white selection mechanism was then employed for replacing PK-GFP cassette in pAd-PK-GFP with a minigene cassette of interest from the pShuttle donor construct. In this case, the white colonies are expected transformants that contain the recombinant adenovirus plasmid. For our study, a pAdCMVEGFP construct carrying enhanced green fluorescent protein gene (EGFP) was isolated by green/white selection. To introduce I-Sec I sites into a pAdCMVEGFP construct, a polylinker containing PacI-I-Sce I recognition sequences was inserted at Pac I sites external to both adenovirus ITRs, resulting in pAdCMVEGFP-I-Sce I. The yeast endonuclease I-Sce I coding region, synthesized by Anagen, Inc. (CA, USA), contains modified codons to optimize expression in mammalian cells. 27 The synthesized I-Sce I sequence was fused at its N-terminus with a nuclear translocation signal (NLS). This fusion was carried out by inserting the I-Sce I sequence downstream of an NLS in a plasmid backbone, removing the NSL-I-Sce I fragment with BspHI and NotI endonuclease digestions and subcloning it into pEF-myc-nuc (Invitrogen, CA, USA), resulting in pEF-Sce I. Expression of I-Sce I is directed by a strong constitutive cellular promoter derived from the human elongation factor I gene. A 293-derived I-Sce I-expressing cell line was generated by transfecting pEF-I-Sce I into 293 cells (ATCC) followed by G418 selection as previously described. 33 Panel c: rescue of self-cleavable adenovirus molecular clone in 293 cells. To create a self-cleavable recombinant adenovirus construct, pAdCMVEGFP-I-Sce I-RSV-I-Sce I, the I-Sce I coding sequence was cloned into pRep-10 (Invitrogene, CA, USA) to generate pRSV-I-SceI. The expression cassette of RSV-I-SceI was subsequently removed by SalI treatment and subcloned into pPuc 19. The RSV-Sce I cassette was excised from pPuc19-RSV-I-SceI by SalI and XhoI digestions and transferred into XhoI site of pX-I-Sce I, a plasmid generated by removal of the AdCMVEGFP genome from pAdCMVEGFP-I-Sce I by PacI digestion and self-ligation, leading to a new construct, pX-I-Sce I-RSV-I-SceI. Finally, the AdCMVEGFP genome was isolated from pAdCMVEGFP-I-Sce I by I-Sce I digestion and subcloned into pX-I-Sce I-RSV-I-SceI at I-Sce I site, resulting in pAdCMVEGFP-I-Sce I-RSV-I-SceI plasmid. Stable 2 (Invitrogene, CA, USA) competent cells were used for all cloning work, following the manufacturer's instructions.
Creation and rescue of molecular clones of Ad vectors G Gao et al expression cassette containing Aequorea victoria green fluorescent protein (GFP). The molecular clone for an adenoviral vector is generated by removing the GFP cassette and inserting a minigene cassette with the gene of interest. This is an inefficient cloning step because of the large size of the plasmid (440 kb). Background bacterial transformants are present due to the incomplete removal of GFP, requiring extensive screening of minipreps. Using the system described above and presented in Figure 1 , we can differentiate background transformants from recombinants because the former fluoresce (ie, green) while the latter do not (ie, white).
With this convenient green/white selection method, a correct recombinant clone is usually guaranteed within less than three white colonies screened. This enabled us to initiate an ambitious functional genomics study using adenovirus vector to evaluate a battery of mouse cDNAs with unknown functions. Using this method, we have cloned more than 100 different minigene cassettes with sizes ranging from 2.5 to 6 kb into PI-Sce I and I-Ceu I sites of the molecular constructs with adenovirus backbones. To isolate those 100 molecular clones, about 400 'white' clones were screened and 382 clones were found to be correct recombinants (Z95%). Although the size of the minigene cassette has less impact on the creation of molecular clones of adenovirus vectors, they often influence the outcome of the rescue process. As previously reported by Bett et al, when the recombinant genomes exceed 105% of the wild-type genome, rescue was more difficult and resulted in viruses that were unstable. Further deletions in other early regions of adenovirus molecular clones and use of appropriate complementing cell lines may be necessary to expand the transgene capacity.
In several independent experiments, we compared circular and linear adenovirus vector genomes with different reporter genes such as LacZ and EGFP, for their transfection efficiency into 293 cells. The circular form consistently achieved two-to three-fold higher transfection efficiency, as examined by numbers of transgene-expressing cells (data not shown). In a proof of concept experiment, 293 cells were transfected with equal amount of either circular or linearized pAdCMVEGFP-I-Sce I plasmid by PacI digestion or circular genome in which the adenovirus sequences are flanked by I-Sce I sites (pAdCMVEGFP-I-SceI), together with pRSV-I-Sce I plasmid, at different molar ratios. Numbers of green plaques were counted at day 10 ( Table 1) . Delivery of a circular molecular clone and in vivo release of vector by I-Sce I in a transient transfection setting led to four-to five-fold higher plaque-forming efficiency, as compared to all other experimental conditions. The molar ratio of the I-Sce I expression plasmid to the substrate plasmid influenced the outcome of the in vitro cleavage and virus rescue process (Table 1) .
In an attempt to further characterize the in vitro cleavage and rescue process of circular adenovirus plasmids, a 293-based cell line stably expressing I-Sce I was created. The efficiencies of the rescue process in 293-I-Sce I and regular 293 cells using circular and linearized pAdCMVEGFP-I-Sce I plasmid by I-Sce I digestion were compared by quantifying numbers of green plaques formed at different time points post-transfection. Circular adenovirus plasmid resulted in no adenovirus rescue in 293 cells. Circular adenovirus plasmid DNA was rescued 10 times more efficiently in the 293-I-Sce I cells than the linearized molecule in either 293 or the 293-ISce I cells (Figure 2) . Additional experiments showed that the efficiency of rescue of the circular plasmid genome in 293-I-Sce I cells increased in proportion to the transfected plasmid ( Figure 3) .
A self-cleaving adenovirus plasmid was created by inserting an I-Sce I expression cassette into the plasmid backbone of pAdCMVEGFP-I-Sce I, called pAdCM-VEGFP-I-Sce I-RSV-I-Sce I. The construct was either treated or untreated with the I-Sec I endonuclease. Circular or linear forms of this self-cleavable construct were transfected into 293 cells in different amounts and green plaques were quantified at day 10. The circular adenovirus plasmid underwent cleavage and rescue in 293 cells with three-to four-fold higher plaquing efficiency as compared to the linear molecule ( Figure  4a) . Alternatively, 293 cells were transfected with equal quantities of circular or predigested pAdCMVEGFP-ISce I-RSV-I-Sce I plasmid with I-Sce I (5 mg) and crude viral lysates were prepared at 10 days post-transfection. a Either linearized or circular adenovirus plasmid DNA (2 mg) along or together with pRSV-I-Sce I plasmid at different molar ratios were transfected into 293 cells in six-well plates and top agar overlaid. Numbers of green plaques were counted at day 10 after agar overlay. The data were from three independent experiments. A limiting step in the use of molecular clones of adenovirus genomes in the production of adenoviruses is that the transfected clone is a poor substrate for initiation of adenovirus DNA replication in mammalian cells, probably due to suboptimal association of viral and cellular replication factors with the DNA substrate of plasmid origin. 30, 31 Although circular molecular clones of adenovirus genomes can be more efficiently transfected into cells, as demonstrated in our study, they are more resistant to viral DNA replication. This is most likely due to decreased initiation of DNA synthesis from plasmid sequences embedded in adenovirus ITRs, as compared to DNA synthesis initiated from ITRs located at the free ends of linear genomes. Thus, release of virus termini from a plasmid backbone in 293 cells facilitates replication of the viral genome and rescue of virus. One approach undertaken was to use a 293 cell line constitutively expressing the adenovirus preterminal protein and DNA polymerase to enhance adenovirus production from transfected circular adenovirus genomes. 23 In our study, in vitro cleavage of adenovirus ITRs from the plasmid backbone by an intron-encoding endonuclease proves to be another effective strategy to improve rescue efficiency of plasmid-bearing adenovirus genomes.
In summary, the green-white selection simplifies cloning of adenovirus molecular clones and improves the cloning efficiency for construction of adenovirus vector plasmids by the direct cloning method. I-Sec Imediated in vitro cleavage of circular adenovirus plasmids enhances the efficiency of adenovirus rescue. These advances in the creation of adenovirus vectors should be useful in high throughput development of adenovirus vectors for genomics and gene therapy research. Creation and rescue of molecular clones of Ad vectors G Gao et al
